Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03558191
What this trial is testing

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 156
Testing effectiveness (Phase 2)Ended earlyNCT00544674
What this trial is testing

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Proacta, Incorporated 5
Testing effectiveness (Phase 2)UnknownNCT03820310
What this trial is testing

Clinical Trial of Autologous Tcm Immunotherapy in ICC

Who this might be right for
Cholangiocarcinoma
Newish Technology (Beijing) Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT00299390
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 10
Early research (Phase 1)Looking for participantsNCT05172310
What this trial is testing

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Who this might be right for
Pancreatic NeoplasmsStomach NeoplasmsBile Duct Neoplasms+1 more
Karolinska University Hospital 410
Testing effectiveness (Phase 2)Ended earlyNCT04352413
What this trial is testing

PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Not applicableUnknownNCT03914820
What this trial is testing

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study.

Who this might be right for
Colorectal Neoplasms
Mario Negri Institute for Pharmacological Research 330
Testing effectiveness (Phase 2)Looking for participantsNCT06790082
What this trial is testing

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

Who this might be right for
Pleural MesotheliomaPleural DiseasesCancer+2 more
Aalborg University Hospital 70
Testing effectiveness (Phase 2)Study completedNCT04247282
What this trial is testing

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Who this might be right for
Head and Neck CancerHead and Neck Neoplasms
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Active Not RecruitingNCT03842982
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)

Who this might be right for
Ovary NeoplasmsOvarian CancerOvarian Carcinoma
Centre Oscar Lambret 362
Not applicableUnknownNCT05580224
What this trial is testing

Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 87
Not applicableUnknownNCT05990959
What this trial is testing

Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

Who this might be right for
Hepatocellular Carcinoma RecurrentSurgery
China Medical University Hospital 800
Very early researchStudy completedNCT03982407
What this trial is testing

68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Ajit H. Goenka, MD 5
Testing effectiveness (Phase 2)Looking for participantsNCT07483307
What this trial is testing

The Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerHER2 Negative Breast Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 176
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Not applicableNot Yet RecruitingNCT06541171
What this trial is testing

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

Who this might be right for
Ovarian CancerRecurrent Ovarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 220
Testing effectiveness (Phase 2)Study completedNCT01636934
What this trial is testing

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Large-scale testing (Phase 3)Study completedNCT03764293
What this trial is testing

Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Locally Advanced or Metastatic and Unresectable HCC
Jiangsu HengRui Medicine Co., Ltd. 543
Not applicableUnknownNCT03150121
What this trial is testing

Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage

Who this might be right for
Ovarian CancerOvarian CarcinomaFallopian Tube Cancer+2 more
Sheba Medical Center 500
Next Page